In recent years, the life science industry has been a primary target for securities fraud class action lawsuits as “nearly one out of every four securities fraud class action lawsuits filed in 2016 was brought against a life sciences company.”1 These fraudulent class action lawsuits have become increasingly common as 2016 highlighted a 70% increase…